semaglutide dose increase chart (Wegovy) for the Treatment of Obesity Semaglutide Dosage Chart for Weight

Patients should: tell their prescriber if they are planning a pregnancy use appropriate contraception where advised stop treatment and seek medical advice if pregnancy occurs discuss alternative treatment when semaglutide is being used for diabetes avoid using GLP-1 medicines during breastfeeding unless specifically advised by an appropriate clinician The MHRA advises that GLP-1 medicines should not be used during pregnancy, while trying to conceive or during breastfeeding because there is insufficient evidence to establish safety for the baby

Outcomes Co-primary endpoints were percentage change in body weight from baseline to week 104 and achievement of weight loss of at least 5% of baseline weight at week 104

Data shows that personalizing doses and slowly tapering semaglutide while following a digital behavior-change program helped many people maintain their target weight for up to six months

It repeatedly pairs the drugs rewarding effects with specific environmental cues

Researchers say the results offer early guidance for designing larger and more detailed studies on whether these medications could be used to help reduce alcohol use

Clinician-led treatment plans often include dietary guidance to help improve tolerance and optimise weight management outcomes